Liposome-coated iron fumarate metal-organic framework nanoparticles for combination therapy

  • Bernhard Illes
  • , Stefan Wuttke
  • , Hanna Engelke

Research output: Contribution to journalArticlepeer-review

77 Citations (Scopus)

Abstract

One of the main problems for effective treatment of cancer is resistances, which often require combination therapy—for effective treatment. While there are already some potential drug carriers—e.g., liposomes, available for treatment—the effective loading and retention of the desired drug ratio can be challenging. To address this challenge, we propose a new type of drug carrier: liposome-coated metal-organic framework (MOF) nanoparticles. They combine the advantages of liposomes with an easy and efficient loading process. In this work, we present the successful synthesis of liposome-coated MOF nanoparticles via the fusion method. The resulting particles, once loaded, show no premature leakage and an efficient release. Their successful loading with both single and multiple drugs at the same time makes them an interesting candidate for use in combination therapy.

Original languageEnglish
Article number351
JournalNanomaterials
Volume7
Issue number11
DOIs
Publication statusPublished - Nov 2017
Externally publishedYes

Keywords

  • Combination therapy
  • Drug delivery
  • Metal-organic framework
  • Nanoparticles

ASJC Scopus subject areas

  • General Chemical Engineering
  • General Materials Science

Fingerprint

Dive into the research topics of 'Liposome-coated iron fumarate metal-organic framework nanoparticles for combination therapy'. Together they form a unique fingerprint.

Cite this